Preliminary Data from Pluristem’s PLC Cell Program Shows Promise in COVID-19

Preliminary Data from Pluristem’s PLC Cell Program Shows Promise in COVID-19

Source: 
BioSpace
snippet: 

The world continues to wait with bated breath for a treatment for COVID-19, and Pluristem Therapeutics appears to be on the cusp of providing some hope. Preliminary data from Israel is showing promise for the company’s experimental treatment.